Company profile for Shape Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide rang...
ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
700 Dexter Ave N Seattle, WA 98109
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/10/3164749/0/en/Shape-Therapeutics-Shares-Breakthrough-Preclinical-Data-for-Non-Invasive-Treatment-of-Parkinson-s-Disease-Using-a-Brain-Targeted-AAV-Gene-Therapy-at-the-European-Society-of-Gene-Ce.html

GLOBENEWSWIRE
10 Oct 2025

https://www.globenewswire.com/news-release/2025/09/26/3157030/0/en/Shape-Therapeutics-Announces-Multiple-Oral-Presentations-at-the-European-Society-of-Gene-Cell-Therapy-32nd-Annual-Congress.html

GLOBENEWSWIRE
26 Sep 2025

https://www.biospace.com/business/vectory-bets-up-to-1-2b-that-shapes-brain-penetrant-capsids-are-a-fit

BIOSPACE
19 Sep 2025

https://www.globenewswire.com/news-release/2025/05/16/3082930/0/en/Shape-Therapeutics-Presents-Preclinical-Data-Highlighting-Therapeutic-Potential-of-RNA-Editing-and-AAV-Delivery-Platforms-at-the-American-Society-of-Gene-and-Cell-Therapy-28th-Annu.html

GLOBENEWSWIRE
16 May 2025

https://www.globenewswire.com/news-release/2025/04/28/3069670/0/en/Shape-Therapeutics-Announces-Multiple-Oral-and-Poster-Presentations-at-the-American-Society-of-Gene-Cell-Therapy-28th-Annual-Meeting.html

GLOBENEWSWIRE
28 Apr 2025

https://www.globenewswire.com/news-release/2024/10/03/2957957/0/en/Shape-Therapeutics-Unveils-Major-Advances-in-AI-Powered-Platform-for-Precision-RNA-Editing.html

GLOBENEWSWIRE
03 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty